Page last updated: 2024-09-05

anacardic acid and 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one

anacardic acid has been researched along with 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one in 1 studies

Compound Research Comparison

Studies
(anacardic acid)
Trials
(anacardic acid)
Recent Studies (post-2010)
(anacardic acid)
Studies
(3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one)
Trials
(3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one)
Recent Studies (post-2010) (3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one)
177112019017

Protein Interaction Comparison

ProteinTaxonomyanacardic acid (IC50)3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.077
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.0503

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, CZ; Guo, H; Hu, X; Klumpp-Thomas, C; Michael, SG; Shen, M; Shinn, P; Xu, M; Zheng, W; Zhu, W1

Other Studies

1 other study(ies) available for anacardic acid and 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one

ArticleYear
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.
    bioRxiv : the preprint server for biology, 2020, Aug-11

    Topics:

2020